+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

EU5 Hormonal Disorders Market Outlook to 2036 - Thyroid Function Tests

  • PDF Icon

    Report

  • 124 Pages
  • May 2026
  • Region: Europe
  • GlobalData
  • ID: 6115080

EU5 Hormonal Disorders Market Outlook to 2036 - Thyroid Function Tests

Summary

The analyst’s “EU5 Hormonal Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the EU5 Hormonal Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Thyroid Function Tests

The EU5 Hormonal Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Hormonal Disorders Market.
  • Global corporate-level profiles of key companies operating within the EU5 Hormonal Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Hormonal Disorders is segmented as follows:

  • Thyroid Function Tests

Reasons to Buy

The EU5 Hormonal Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Hormonal Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hormonal Disorders Market, EU5
2.1 Hormonal Disorders Market, EU5, Revenue ($m), 2024-2036
2.2 Hormonal Disorders Market, EU5, Revenue ($m), 2024-2036
2.3 Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
2.4 Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
2.5 Hormonal Disorders Market, EU5, Company Share by Revenue ($m), 2025
3 Hormonal Disorders Market, France
3.1 Hormonal Disorders Market, France, Revenue ($m), 2024-2036
3.1.1 Thyroid Function Tests Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Hormonal Disorders Market, France, Volume (Units), 2024-2036
3.2.1 Thyroid Function Tests Market, France, Volume (Units), by Segment, 2024-2036
3.3 Hormonal Disorders Market, France, Average Price ($), 2024-2036
3.4 Hormonal Disorders Market, France, Company Share by Revenue ($m), 2025
4 Hormonal Disorders Market, Germany
4.1 Hormonal Disorders Market, Germany, Revenue ($m), 2024-2036
4.1.1 Thyroid Function Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
4.2.1 Thyroid Function Tests Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Hormonal Disorders Market, Germany, Average Price ($), 2024-2036
4.4 Hormonal Disorders Market, Germany, Company Share by Revenue ($m), 2025
5 Hormonal Disorders Market, Italy
5.1 Hormonal Disorders Market, Italy, Revenue ($m), 2024-2036
5.1.1 Thyroid Function Tests Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Hormonal Disorders Market, Italy, Volume (Units), 2024-2036
5.2.1 Thyroid Function Tests Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Hormonal Disorders Market, Italy, Average Price ($), 2024-2036
5.4 Hormonal Disorders Market, Italy, Company Share by Revenue ($m), 2025
6 Hormonal Disorders Market, Spain
6.1 Hormonal Disorders Market, Spain, Revenue ($m), 2024-2036
6.1.1 Thyroid Function Tests Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Hormonal Disorders Market, Spain, Volume (Units), 2024-2036
6.2.1 Thyroid Function Tests Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Hormonal Disorders Market, Spain, Average Price ($), 2024-2036
6.4 Hormonal Disorders Market, Spain, Company Share by Revenue ($m), 2025
7 Hormonal Disorders Market, United Kingdom
7.1 Hormonal Disorders Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Thyroid Function Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Hormonal Disorders Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Thyroid Function Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Hormonal Disorders Market, United Kingdom, Average Price ($), 2024-2036
7.4 Hormonal Disorders Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Hormonal Disorders Market Pipeline Products
8.1 Hormonal Disorders Market Pipeline Products
8.2 Hormonal Disorders - Pipeline Products by Stage of Development
8.3 Hormonal Disorders - Pipeline Products by Segment
8.4 Hormonal Disorders - Pipeline Products by Territory
8.5 Hormonal Disorders - Pipeline Products by Regulatory Path
8.6 Hormonal Disorders - Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in EU5 Hormonal Disorders Market
9.1 Siemens Healthineers AG
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Roche Diagnostics International Ltd
9.3.1 Company Overview
9.4 Beckman Coulter Inc
9.4.1 Company Overview
9.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
9.5.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Nov 05, 2025: Waardenburg Syndrome and Piebaldism
10.1.2 Nov 03, 2025: Androstenedione Elisa - New Release
10.1.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.4 Oct 21, 2025: Novo Nordisk Foundation Proposes New Board Members for Novo Nordisk A/S
10.1.5 Oct 16, 2025: Reflections On Diagnostics At IPSC 2025
10.1.6 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
10.2 Financial Announcements
10.2.1 Feb 05, 2026: Siemens Healthineers Announces Q1 Results for Fiscal Year 2026
10.2.2 Nov 13, 2025: Integrated Diagnostics Holdings Delivers 41% Revenue Growth in 9M 2025 With Continued Margin Expansion and Robust Bottom-Line Performance
10.3 Government and Public Interest
10.3.1 Jan 12, 2026: Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference
10.4 Other Significant Developments
10.4.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.4.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.5 Product News
10.5.1 Feb 17, 2026: BioMed X Launches XFem Labs Women's Health Accelerator With Pitch Event
10.5.2 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.5.3 Nov 14, 2025: Scientists Invent New Method for Producing Platelet-Producing Cells from Stem Cells
10.5.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.5.5 Oct 30, 2025: FNCC RR Showcases Innovative Developments at All-Russian Exhibition
10.5.6 Sep 19, 2025: University of Turku Launches ICDx Project for Commercialization of Next-Generation Hormone Tests
10.6 Research And Development
10.6.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.7 Strategy And Business Planning
10.7.1 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.7.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.7.3 Oct 22, 2025: HMI Medical Expands Imaging Services in Singapore
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer
List of Tables
Table 1: Hormonal Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Table 2: Hormonal Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
Table 4: Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
Table 5: Hormonal Disorders Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Hormonal Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Thyroid Function Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Hormonal Disorders Market, France, Volume (Units), 2024-2036
Table 9: Thyroid Function Tests Market, France, Volume (Units), 2024-2036
Table 10: Hormonal Disorders Market, France, Average Price ($), 2024-2036
Table 11: Hormonal Disorders Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 12: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 13: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 14: Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
Table 15: Thyroid Function Tests Market, Germany, Volume (Units), 2024-2036
Table 16: Hormonal Disorders Market, Germany, Average Price ($), 2024-2036
Table 17: Hormonal Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 18: Hormonal Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 19: Thyroid Function Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 20: Hormonal Disorders Market, Italy, Volume (Units), 2024-2036
Table 21: Thyroid Function Tests Market, Italy, Volume (Units), 2024-2036
Table 22: Hormonal Disorders Market, Italy, Average Price ($), 2024-2036
Table 23: Hormonal Disorders Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 24: Hormonal Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 25: Thyroid Function Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 26: Hormonal Disorders Market, Spain, Volume (Units), 2024-2036
Table 27: Thyroid Function Tests Market, Spain, Volume (Units), 2024-2036
Table 28: Hormonal Disorders Market, Spain, Average Price ($), 2024-2036
Table 29: Hormonal Disorders Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Hormonal Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 31: Thyroid Function Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 32: Hormonal Disorders Market, United Kingdom, Volume (Units), 2024-2036
Table 33: Thyroid Function Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 34: Hormonal Disorders Market, United Kingdom, Average Price ($), 2024-2036
Table 35: Hormonal Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Hormonal Disorders Market Pipeline Products
Table 37: Hormonal Disorders - Pipeline Products by Stage of Development
Table 38: Hormonal Disorders Companies - Pipeline Products by Stage of Development
Table 39: Hormonal Disorders - Pipeline Products by Segment
Table 40: Hormonal Disorders - Pipeline Products by Territory
Table 41: Hormonal Disorders - Pipeline Products by Regulatory Path
Table 42: Hormonal Disorders - Pipeline Products by Estimated Approval Date
Table 43: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hormonal Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hormonal Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
Figure 4: Hormonal Disorders Market, EU5, Volume (Units), 2024-2036
Figure 5: Hormonal Disorders Market, EU5, Company Share (%), 2025
Figure 6: Hormonal Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Thyroid Function Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Hormonal Disorders Market, France, Volume (Units), 2024-2036
Figure 9: Thyroid Function Tests Market, France, Volume (Units), 2024-2036
Figure 10: Hormonal Disorders Market, France, Company Share (%), 2025
Figure 11: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 12: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 13: Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
Figure 14: Thyroid Function Tests Market, Germany, Volume (Units), 2024-2036
Figure 15: Hormonal Disorders Market, Germany, Company Share (%), 2025
Figure 16: Hormonal Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 17: Thyroid Function Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 18: Hormonal Disorders Market, Italy, Volume (Units), 2024-2036
Figure 19: Thyroid Function Tests Market, Italy, Volume (Units), 2024-2036
Figure 20: Hormonal Disorders Market, Italy, Company Share (%), 2025
Figure 21: Hormonal Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 22: Thyroid Function Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 23: Hormonal Disorders Market, Spain, Volume (Units), 2024-2036
Figure 24: Thyroid Function Tests Market, Spain, Volume (Units), 2024-2036
Figure 25: Hormonal Disorders Market, Spain, Company Share (%), 2025
Figure 26: Hormonal Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 27: Thyroid Function Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 28: Hormonal Disorders Market, United Kingdom, Volume (Units), 2024-2036
Figure 29: Thyroid Function Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 30: Hormonal Disorders Market, United Kingdom, Company Share (%), 2025
Figure 31: Hormonal Disorders - Pipeline Products by Stage of Development
Figure 32: Hormonal Disorders - Pipeline Products by Segment
Figure 33: Hormonal Disorders - Pipeline Products by Territory
Figure 34: Hormonal Disorders - Pipeline Products by Regulatory Path
Figure 35: Hormonal Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Abbott Laboratories
  • Roche Diagnostics International Ltd
  • Beckman Coulter Inc
  • Ortho Clinical Diagnostics Holdings Ltd (Inactive)